NSE: GALAXYSURF | BSE: 540935

Slowing Down Stock

Download real time

1903.70 0.10 (0.01%)

Near 52W Low of ₹1865.00

5,680 NSE+BSE Volume

NSE 23 Jan, 2026 3:31 PM (IST)

6,749.5

Market Cap

High in industry

Beta 1Year

Very Low volatility

Galaxy Surfactants Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for GALAXYSURF, BSE:540935 Galaxy Surfactants Ltd.

Search Inside the pdf :

Galaxy Surfactants Ltd.

13 Nov 2025

1903.70

0.01%

Macro headwinds hurt volume growth

Buy: Galaxy Surfactants Ltd.

Target

Motilal Oswal

Galaxy Surfactants (GALSURF) delivered a weak quarter, with EBITDA declining 13% YoY. EBITDA/kg stood at ~INR17, down 11% YoY in 2QFY26, primarily due to global tariff headwinds, reformulation within the performance segment, and lower domestic volumes following GST-driven inventory adjustments.

Galaxy Surfactants Ltd. is trading below all available SMAs

Galaxy Surfactants Ltd.

14 Aug 2025

1903.70

0.01%

RoW continues to support sales growth

Buy: Galaxy Surfactants Ltd.

Target

Motilal Oswal

Galaxy Surfactants (GALSURF) reported an EBITDA/kg of INR18.4 (est. INR19.3), down 5% YoY, while total volumes increased ~5% YoY to 67.3tmt (vs. est 64.4tmt), supported by robust growth in the RoW region (up 16% YoY) driven by LATAM and APAC.

Galaxy Surfactants L.. has an average target of 2570.00 from 2 brokers.

Galaxy Surfactants Ltd.

14 Jul 2025

1903.70

0.01%

Company Update:Galaxy Surfact.

Not Rated: Galaxy Surfactants Ltd.

Axis Direct

The stock is currently not under our coverage, and we do not have a view on the same. The stock currently trades at 29x of its FY25 EPS.

Galaxy Surfactants has lost -25.82% in the last 6 Months

Galaxy Surfactants Ltd.

16 Jun 2025

1903.70

0.01%

Scaling with strategic clarity and focus

Buy: Galaxy Surfactants Ltd.

Target

Motilal Oswal

Over the past 10 years, GALSURF has demonstrated its ability to scale profitably while navigating cyclical and regional challenges.

Galaxy Surfactants L.. has an average target of 2570.00 from 2 brokers.

Galaxy Surfactants Ltd.

22 May 2024

1903.70

0.01%

As expected, EBITDA/kg guidance raised by INR 1 to INR 20.5–21.5 for FY25E

Hold: Galaxy Surfactants Ltd.

Target

ICICI Securities Limited

Galaxy Surfactants’ (GSL) Q4FY24 EBITDA/kg stood at INR 16.9, down 27.2% YoY, was hurt from higher freight cost and lower volumes due to the Red Sea issue

Galaxy Surfactants L.. has an average target of 2570.00 from 2 brokers.

Galaxy Surfactants Ltd.

22 May 2024

1903.70

0.01%

Volume and margin guidance remains intact

Buy: Galaxy Surfactants Ltd.

Target

Motilal Oswal

Galaxy Surfactants (GALSURF) reported EBITDA/kg of INR16.7 in 4QFY24, down
28% YoY (our estimate of INR22.5). The company achieved a total volume
growth of ~5% YoY to 60.8tmt (our est. of 60.4tmt), with healthy volume growth
in India and RoW regions.

Galaxy Surfactants Ltd. is trading below all available SMAs

Galaxy Surfactants Ltd.

10 Apr 2024

1903.70

0.01%

FY25E – volumes to moderate, margins to improve

Hold: Galaxy Surfactants Ltd.

Target

ICICI Securities Limited

In the last three years, Galaxy Surfactants (Galaxy) has grappled with a variety of challenges, yet delivered consistent earnings thanks to its robust business model and diversified portfolio. After a strong FY24E (+9.2%), we envisage Galaxy’s volumes slowing as India growth moderates while AMET improves.

Number of FII/FPI investors decreased from 118 to 110 in Dec 2025 qtr

Galaxy Surfactants Ltd.

12 Nov 2023

1903.70

0.01%

Robust overall volumes led by growth across markets

Buy: Galaxy Surfactants Ltd.

Target

Motilal Oswal

Galaxy Surfactants has lost -25.82% in the last 6 Months

Galaxy Surfactants Ltd.

15 Aug 2023

1903.70

0.01%

EBITDA to grow in FY24 despite weak start in Q1

Hold: Galaxy Surfactants Ltd.

Target

ICICI Securities Limited

Galaxy Surfactants’ (GSL) Q1FY24 EBITDA/kg stood at INR 20.8, down 16.8% YoY. Volume growth was steady at 7.4%. India volume continues to be strong; AMET has stabilised at low levels, and RoW has been impacted by the de-stocking in North America.